Table 1

Baseline values for all patients (n = 9)

Baseline characteristics


Gender (female/male)

3/6

Age (years)*

72 (51–86)

Body-mass index (kg/m2)*

25.9 (24.7–33.7)

Smoking (pack years)*

30 (25–50)

Duration of COPD (years)*

2.0 (1–4)

Number of AECOPD in previous year*

1 (1–2)

Duration of AECOPD (days)

4 (4–7)

Dyspnea (%)

9 (100%)

Cough (%)

9 (100%)

Increased sputum production (%)

9 (100%)

Discoloured sputum (%)

7 (78%)

Fever (%)

7 (78%)

Maintenance therapy at admission (%)

β2-agonist and/or anticholinergic

7 (78%)

Inhaled corticosteroids

4 (44%)

Oral corticosteroids

0 (0%)

Theophyllin

0 (0%)

Long-term oxygen therapy

1 (11%)

Severity of AECOPD – Anthonisen's criteria [8] (%)

1

0 (0%)

2

2 (22%)

3

7 (78%)


Heart rate* (beats/min)

84 (70–101)


Blood pressure* (mmHg)

Systolic

143 (120–150)

Diastolic

80 (69–85)


Respiratory rate*

16 (12–25)


Laboratory findings:


Leukocytes total*

9.3 (7.7–10.1)

CRP (mg/dl)*

19 (6–61)

Cortisol basal (nmol/l)**

439 (392–462)

Cortisol after 1 μg ACTH (nmol/l)**

712 (608–730)

Basal ACTH (ng/l)**

9.2 (5.1–11.5)


* median, interquartile range;

Schuetz et al. BMC Pulmonary Medicine 2008 8:1   doi:10.1186/1471-2466-8-1

Open Data